We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Aptamer Group

News List

Aptamer Group and WuXi AppTec Research Service Division collaborate to identify new Optimer enabled therapeutics firstwordpharma
July 23, 2021
Aptamer Group, the developer of Optimer™ therapeutics and diagnostics, and WuXi AppTec Research Service Division, an integrated chemistry and biology research platform, today announce a research collaboration to identify new Optimer™-enabled therapeutics.
Aptamer Group: UK Biotech Business Raises $2.2M Investment b3cnewswire
July 24, 2018
Rapidly growing biotech business, Aptamer Group Ltd, has closed its Series A investment round after attracting international interest, securing $2.2m of funding from overseas investors to support its pioneering aptamer development programme.
Aptamer Group: UK Biotech Business Raises $2.2M Investment b3cnewswire
July 04, 2018
Rapidly growing biotech business, Aptamer Group Ltd, has closed its Series A investment round after attracting international interest, securing $2.2m of funding from overseas investors to support its pioneering aptamer development programme.